Resmonics

Resmonics AG is a global market leader for acoustic artificial intelligence for clinical use. We unlock the power of sound for medicine by objectively detecting and analyzing symptoms to empower patients and their doctors in everyday life. Our first product is a CE-certified software as a medical device that enables medically meaningful cough analytics on smartphones and other smart devices. The product is used by our diverse international customer base with corporate clients from Switzerland, Finland, and China.

The company is an award-winning spin-off from ETH Zürich, one of the world's top 10 universities, it was founded in 2020 and is led by Dr. Peter Tinschert and David Cleres. Our products are based on research conducted at leading Swiss healthcare providers. For more information, please visit www.resmonics.ai.